Bimekizumab Leads to Sustained Flare-Free Status in Moderate to Severe Hidradenitis Suppurativa: 3-Year Data from BE HEARD EXT

Skin · Published 2026-07-14 · DOI 10.25251/hbdp2440

Free full text

Authors (9)

Steven Daveluy, Haley B. Naik, Ziad Reguiai, Sayaka Yamaguchi, Pablo Fernández-Peñas, Bartosz Lukowski, Christina Crater, Nicola Tilt, Antonio Martorell

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Daveluy, S., Naik, H., Reguiai, Z., et al. (2026). Bimekizumab Leads to Sustained Flare-Free Status in Moderate to Severe Hidradenitis Suppurativa: 3-Year Data from BE HEARD EXT. Skin. https://doi.org/10.25251/hbdp2440

Related articles

• Unanticipated Skin Discovery at the Lateral Thigh · Skin · 2026 · Same journal
• Real-World Safety and Effectiveness of Up to 12 Months of Tralokinumab Treatment in Adults With Atopic Dermatitis Who Discontinued Dupilumab Due to Conjunctivitis · Skin · 2026 · Same journal
• Chronic Trichophyton indotineae Infections Mimicking Adult-Onset Atopic Dermatitis · Skin · 2026 · Same journal
• Severe Psoriasis Leading to Scarring Alopecia of the Scalp Responding to Biologic Therapy · Skin · 2026 · Same journal
• A Case of Erdheim-Chester Disease in a Patient with Langerhans Cell Histiocytosis · Skin · 2026 · Same journal
• Eruptive Cutaneous Metastatic Leiomyosarcoma · Skin · 2026 · Same journal
• Pilot Evaluation of the Efficacy and Safety of Xtressé™ Gummy-Based Nutraceutical Supplement in Women with Hair Loss · Skin · 2026 · Same journal
• When to Reapply Moisturizers: Evidence-Based Intervals from a 24-Hour Hydration Study · Skin · 2026 · Same journal
• Rethinking the Rule of Halves: A Centripetal Suturing Technique to Minimize Dog-Ear Formation · Skin · 2026 · Same journal
• Restorative Oncodermatology: Piloting an Educational Pamphlet to Address Dermatologic Sequelae in Cancer Survivors · Skin · 2026 · Same journal